Application Sponsors
ANDA 040797 | INVAGEN PHARMS | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET;ORAL | 200MG | 0 | MEPROBAMATE | MEPROBAMATE |
002 | TABLET;ORAL | 400MG | 0 | MEPROBAMATE | MEPROBAMATE |
FDA Submissions
TE Codes
001 | Prescription | AA |
002 | Prescription | AA |
CDER Filings
INVAGEN PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 40797
[companyName] => INVAGEN PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"MEPROBAMATE","activeIngredients":"MEPROBAMATE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MEPROBAMATE","activeIngredients":"MEPROBAMATE","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"MEPROBAMATE","submission":"MEPROBAMATE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"MEPROBAMATE","submission":"MEPROBAMATE","actionType":"400MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)